Safety, pharmacokinetics (PK), and clinical activity of bezuclastinib + sunitinib in previously-treated gastrointestinal stromal tumor (GIST): Results from part 1 of the phase 3 Peak study Meeting Abstract
| Authors: | Tap, W. D.; Wagner, A. J.; Bauer, S.; Heinrich, M. C.; Jones, R. L.; Serrano, C.; von Mehren, M.; Somaiah, N.; Andor, T.; Zou, L.; Exter, B.; Lawrence, J.; LaHaie, C.; Mitchell, S.; Moynihan, K.; Sachs, J.; Sun, L.; Trent, J. C. |
| Abstract Title: | Safety, pharmacokinetics (PK), and clinical activity of bezuclastinib + sunitinib in previously-treated gastrointestinal stromal tumor (GIST): Results from part 1 of the phase 3 Peak study |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.11537 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstract: 11537 -- Meeting also presented virtually -- Source: Cinahl |
